Boys with DMD get continued access to promising steroid alternative
Disease control
AVAILABLE
This program offers ongoing access to vamorolone, a steroid-like drug, for boys with Duchenne muscular dystrophy who finished earlier studies. It aims to keep them on treatment while the drug is being reviewed for approval. Participants take vamorolone daily by mouth at doses cho…
Sponsor: Santhera Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC